×
-0.000664162283996835 0.00135236664162289 -0.000300525920360571 -0.000150262960180179 -0.00435762584522903 -0.00796393688955653 -0.00676183320811403 -0.00622389181066858
Stock impact report

AbbVie is shutting down its troubled Rova-T R&D program [MarketWatch]

AbbVie, Inc (ABBV)  More Company Research Source: MarketWatch
Last abbvie, inc earnings: 11/1 07:47 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF AbbVie is shutting down its troubled Rova-T R&D program Shares of AbbVie Inc. ABBV, +0.74% rose 1.5% in premarket trade Thursday after the company announced it had shut down its troubled Rova-T research and development program. The drugmaker said it was discontinuing a late-stage trial of Rova-T as a potential treatment for advanced small-cell lung cancer after interim data showed patients on the drug had no survival benefit compared with those on placebo. "Small-cell lung cancer continues to be one of the most difficult-to-treat cancers where there is a significant need for transformative therapies. We are disappointed with this outcome for the patients who suffer from this disease," said Margaret Foley, global head of solid tumor development at AbbVie. The closure of the Rova-T program comes after several other trial setbacks for the drug. AbbVie bought Stemcentrx and its prized investigational drug in 2016 for $5.8 billion in cash and stock, but was forced to put down an impairm [Read more]
Impact snapshot Event time: ABBV
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ABBV alerts
from News Quantified
Opt-in for
ABBV alerts

from News Quantified
Opt-in for
ABBV alerts

from News Quantified